Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Revenue

Orchid Pharma had revenue of 1.94B INR in the quarter ending September 30, 2025, a decrease of -13.10%. This brings the company's revenue in the last twelve months to 8.21B, down -9.23% year-over-year. In the fiscal year ending March 31, 2025, Orchid Pharma had annual revenue of 9.22B with 12.52% growth.

• Revenue (ttm): 8.21B
• Revenue Growth: -9.23%
• P/S Ratio: 4.25
• Revenue / Employee: 11.16M
• Employees: 736
• Market Cap: 34.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	9.22B	1.03B	12.52%
Mar 31, 2024	8.19B	1.53B	23.05%
Mar 31, 2023	6.66B	1.06B	19.00%
Mar 31, 2022	5.60B	1.09B	24.33%
Mar 31, 2021	4.50B	-337.41M	-6.97%